FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201747426> ?p ?o ?g. }

• W3201747426 abstract "Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would be useful for clinical practice and policy decision-making on allocating resources effectively. This study aimed to update a systematic review on economic evaluations of pharmacogenetic testing to prevent ADRs and critically appraise the quality of reporting and sources of evidence for model input parameters.We searched studies through Medline via PubMed, Scopus and CRD's NHS Economic Evaluation up to October 2019. Studies investigating polymorphism-based pharmacogenetic testing, which guided drug therapies to prevent ADRs, using economic evaluation methods were included. Two reviewers independently performed data extraction and assessed the quality of reporting using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) guidelines and the quality of data sources using the hierarchy of evidence developed by Cooper et al. RESULTS: Fifty-nine economic evaluations of pharmacogenetic testing to avoid drug-induced ADRs were found between 2002 and 2018. Cost-utility and cost-effectiveness analyses were the most common methods of economic evaluation of pharmacogenetic testing. Most studies complied with the CHEERS checklist, except for single study-based economic evaluations which did not report uncertainty analysis (78%). There was a lack of high-quality evidence not only for estimating the clinical effectiveness of pharmacogenetic testing, but also baseline clinical data. About 14% of the studies obtained clinical effectiveness data of testing from a meta-analysis of case-control studies with direct comparison, which was not listed in the hierarchy of evidence used.Our review suggested that future single study-based economic evaluations of pharmacogenetic testing should report uncertainty analysis, as this could significantly affect the robustness of economic evaluation results. A specific ranking system for the quality of evidence is needed for the economic evaluation of pharmacogenetic testing of ADRs. Differences in parameters, methods and outcomes across studies, as well as population-level and system-level differences, may lead to the difficulty of comparing cost-effectiveness results across countries." @default.
• W3201747426 created "2021-10-11" @default.
• W3201747426 creator A5012424756 @default.
• W3201747426 creator A5030389292 @default.
• W3201747426 creator A5031146895 @default.
• W3201747426 creator A5052551841 @default.
• W3201747426 creator A5068698556 @default.
• W3201747426 creator A5069879667 @default.
• W3201747426 date "2021-10-02" @default.
• W3201747426 modified "2023-10-10" @default.
• W3201747426 title "Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation" @default.
• W3201747426 cites W1487649173 @default.
• W3201747426 cites W1597380779 @default.
• W3201747426 cites W1662226698 @default.
• W3201747426 cites W1885281724 @default.
• W3201747426 cites W1967710844 @default.
• W3201747426 cites W1969879564 @default.
• W3201747426 cites W1981978891 @default.
• W3201747426 cites W1984185385 @default.
• W3201747426 cites W1984954114 @default.
• W3201747426 cites W1987938439 @default.
• W3201747426 cites W1989868349 @default.
• W3201747426 cites W1989978053 @default.
• W3201747426 cites W2004760338 @default.
• W3201747426 cites W2005705037 @default.
• W3201747426 cites W2007182242 @default.
• W3201747426 cites W2007836516 @default.
• W3201747426 cites W2009674096 @default.
• W3201747426 cites W2018431503 @default.
• W3201747426 cites W2023000498 @default.
• W3201747426 cites W2025100003 @default.
• W3201747426 cites W2026017382 @default.
• W3201747426 cites W2035225982 @default.
• W3201747426 cites W2042672137 @default.
• W3201747426 cites W2045776918 @default.
• W3201747426 cites W2049471379 @default.
• W3201747426 cites W2049501844 @default.
• W3201747426 cites W2059533196 @default.
• W3201747426 cites W2062245141 @default.
• W3201747426 cites W2063280109 @default.
• W3201747426 cites W2065874658 @default.
• W3201747426 cites W2067315990 @default.
• W3201747426 cites W2071999091 @default.
• W3201747426 cites W2078601367 @default.
• W3201747426 cites W2082126453 @default.
• W3201747426 cites W2102788703 @default.
• W3201747426 cites W2103542844 @default.
• W3201747426 cites W2103792822 @default.
• W3201747426 cites W2105178715 @default.
• W3201747426 cites W2112182958 @default.
• W3201747426 cites W2114365596 @default.
• W3201747426 cites W2116333054 @default.
• W3201747426 cites W2117877853 @default.
• W3201747426 cites W2126243421 @default.
• W3201747426 cites W2129897459 @default.
• W3201747426 cites W2134049088 @default.
• W3201747426 cites W2137364748 @default.
• W3201747426 cites W2138969220 @default.
• W3201747426 cites W2143025931 @default.
• W3201747426 cites W2143532751 @default.
• W3201747426 cites W2145602800 @default.
• W3201747426 cites W2145890930 @default.
• W3201747426 cites W2147670494 @default.
• W3201747426 cites W2150712216 @default.
• W3201747426 cites W2156023253 @default.
• W3201747426 cites W2156098321 @default.
• W3201747426 cites W2157065952 @default.
• W3201747426 cites W2157117527 @default.
• W3201747426 cites W2157450846 @default.
• W3201747426 cites W2162991569 @default.
• W3201747426 cites W2164386459 @default.
• W3201747426 cites W2164705071 @default.
• W3201747426 cites W2167706426 @default.
• W3201747426 cites W2170348999 @default.
• W3201747426 cites W2170468317 @default.
• W3201747426 cites W2172024692 @default.
• W3201747426 cites W2173347118 @default.
• W3201747426 cites W2174633205 @default.
• W3201747426 cites W2301396653 @default.
• W3201747426 cites W2306473868 @default.
• W3201747426 cites W2324741940 @default.
• W3201747426 cites W2418621767 @default.
• W3201747426 cites W2468996569 @default.
• W3201747426 cites W2513072880 @default.
• W3201747426 cites W2545779875 @default.
• W3201747426 cites W2548080299 @default.
• W3201747426 cites W2559816575 @default.
• W3201747426 cites W2570404502 @default.
• W3201747426 cites W2580858561 @default.
• W3201747426 cites W2594351722 @default.
• W3201747426 cites W2598674670 @default.
• W3201747426 cites W2603136056 @default.
• W3201747426 cites W2735446982 @default.
• W3201747426 cites W2763926159 @default.
• W3201747426 cites W2770163795 @default.
• W3201747426 cites W2794433174 @default.
• W3201747426 cites W2799963449 @default.
• W3201747426 cites W2918342502 @default.
• W3201747426 cites W3037787715 @default.
• W3201747426 cites W3140662180 @default.

• next